The report analyzes and forecasts the pulmonary drug delivery devices market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of pulmonary drug delivery devices, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major pulmonary drug delivery devices companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of pulmonary drug delivery devices upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of pulmonary drug delivery devices and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global pulmonary drug delivery devices market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the pulmonary drug delivery devices market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of pulmonary drug delivery devices market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Key players in the market include AstraZeneca plc., Boehringer Ingelheim Gmbh, GlaxoSmithKline plc, Novartis AG, Koninklijke Philips N.V., 3M company, Actelion Pharmaceuticals Ltd, Clement Clarke International, Briggs Healthcare, and Aerogen.
Report Segmentation:
Product Outlook
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Mesh
Vibrating
Static
Pneumatic
Vented
Breath Actuated
Ultrasonic
Accessories
Application Outlook
Asthma
Cystic Fibrosis
COPD
Allergic Rhinitis
Others
Distribution Channel Outlook
Retail Pharmacies
Hospital Pharmacies
E-Commerce
End-use Outlook
Hospitals & Clinics
Homecare
Regional Outlook
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Table of Contents
Chapter 1 Research Methodology
1.1 Region Wise Market Calculation
1.1.1 Region wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Pulmonary Drug Delivery Systems Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing incidence of respiratory diseases
3.2.2 Technological advancements
3.2.3 Increasing initiatives from public and private organizations
3.3 Market Restraint Analysis
3.3.1 Regulatory issues and patent expiry of blockbuster drugs
3.4 Penetration & Growth Prospect Mapping
3.5 Pulmonary Drug Delivery Systems - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
3.7 Company Market Share, 2018
Chapter 4 Pulmonary Drug Delivery Systems Market: Product Estimates & Trend Analysis
4.1 Pulmonary Drug Delivery Systems Market: Product Movement Analysis
4.2 Metered Dose Inhalers (MDIs)
4.2.1 Metered dose inhalers (MDIs) market, 2017 - 2026 (USD Million)
4.3 Dry Powder Inhalers (DPIs)
4.3.1 Dry powder inhalers (DPIs)market, 2017 - 2026 (USD Million)
4.4 Nebulizers
4.4.1 Nebulizers market, 2017 - 2026 (USD Million)
4.4.2 Mesh nebulizers
4.4.2.1 Mesh nebulizers market, 2017 - 2026 (USD Million)
4.4.2.2 Vibrating mesh nebulizers
4.4.2.2.1 Vibrating mesh nebulizers market, 2017 - 2026 (USD Million)
4.4.2.3 Static mesh nebulizers
4.4.2.3.1 Static mesh nebulizers market, 2017 - 2026 (USD Million)
4.4.3 Pneumatic nebulizers
4.4.3.1 Pneumatic nebulizers market, 2017 - 2026 (USD Million)
4.4.3.2 Vented pneumatic nebulizers
4.4.3.2.1 Vented pneumatic nebulizers market, 2017 - 2026 (USD Million)
4.4.3.3 Breath actuated pneumatic nebulizers
4.4.3.3.1 Breath actuated pneumatic nebulizers market, 2017 - 2026 (USD Million)
4.4.4 Ultrasonic nebulizers
4.4.4.1 Ultrasonic nebulizers market, 2017 - 2026 (USD Million)
4.5 Accessories
4.5.1 Accessories market, 2017 - 2026 (USD Million)
Chapter 5 Pulmonary Drug Delivery Systems Market: Application Estimates & Trend Analysis
5.1 Pulmonary Drug Delivery Systems Market: Application Movement Analysis
5.2 Asthma
5.2.1 Asthma market, 2017 - 2026 (USD Million)
5.3 Cystic Fibrosis
5.3.1 Cystic fibrosis market, 2017 - 2026 (USD Million)
5.4 Chronic Obstructive Pulmonary Disease
5.4.1 Chronic obstructive pulmonary disease market, 2017 - 2026 (USD Million)
5.5 Allergic Rhinitis
5.5.1 Allergic rhinitis market, 2017 - 2026 (USD Million)
5.6 Others
5.6.1 Others market, 2017 - 2026 (USD Million)
Chapter 6 Pulmonary Drug Delivery Systems Market: Distribution Channel Estimates & Trend Analysis
6.1 Pulmonary Drug Delivery Systems Market: Distribution Channel Movement Analysis
6.2 Retail Pharmacies
6.2.1 Retail pharmacies market, 2017 - 2026 (USD Million)
6.3 Hospital Pharmacies
6.3.1 Hospital pharmacies market, 2017 - 2026 (USD Million)
6.4 E-Commerce
6.4.1 E-commercemarket, 2017 - 2026 (USD Million)
Chapter 7 Pulmonary Drug Delivery Systems Market: End Use Estimates & Trend Analysis
7.1 Pulmonary Drug Delivery Systems Market: End Use Movement Analysis
7.2 Hospitals & Clinics
7.2.1 Hospitals & clinics market, 2017 - 2026 (USD Million)
7.3 Homecare
7.3.1 Homecare market, 2017 - 2026 (USD Million)
Chapter 8 Pulmonary Drug Delivery Systems Market: Regional Estimates & Trend Analysis, by Product, Application, Distribution Channel, and End Use
8.1 Pulmonary Drug Delivery Systems Market Share by Region, 2018& 2026
8.2 North America
8.2.1 North America pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
8.2.2 North America pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.2.3 North America pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.2.4 North America pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.2.5 North America pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.2.6 U.S.
8.2.6.1 U.S. pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.2.6.2 U.S. pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.2.6.3 U.S. pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.2.6.4 U.S. pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.2.7 Canada
8.2.7.1 Canada pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.2.7.2 Canada pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.2.7.3 Canada pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.2.7.4 Canada pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.3 Europe
8.3.1 Europe pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
8.3.2 Europe pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.3.3 Europe pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.3.4 Europe pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.3.5 Europe pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.3.6 UK
8.3.6.1 UK pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.3.6.2 UK pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.3.6.3 UK pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.3.6.4 UK pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.3.7 Germany
8.3.7.1 Germany pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.3.7.2 Germany pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.3.7.3 Germany pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.3.7.4 Germany pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
8.4.2 Asia Pacific pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.4.3 Asia Pacific pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.4.4 Asia Pacific pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.4.5 Asia Pacific pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.4.6 Japan
8.4.6.1 Japan pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.4.6.2 Japan pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.4.6.3 Japan pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.4.6.4 Japan pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.4.7 China
8.4.7.1 China pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.4.7.2 China pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.4.7.3 China pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.4.7.4 China pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.4.8 India
8.4.8.1 India pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.4.8.2 India pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.4.8.3 India pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.4.8.4 India pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.5 Latin America
8.5.1 Latin America pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
8.5.2 Latin America pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.5.3 Latin America pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.5.4 Latin America pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.5.5 Latin America pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.5.6 Brazil
8.5.6.1 Brazil pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.5.6.2 Brazil pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.5.6.3 Brazil pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.5.6.4 Brazil pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.5.7 Mexico
8.5.7.1 Mexico pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.5.7.2 Mexico pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.5.7.3 Mexico pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.5.7.4 Mexico pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.6 MEA
8.6.1 MEA pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
8.6.2 MEA pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.6.3 MEA pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.6.4 MEA pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.6.5 MEA pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
8.6.6 South Africa
8.6.6.1 South Africa pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
8.6.6.2 South Africa pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
8.6.6.3 South Africa pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
8.6.6.4 South Africa pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation
9.3 Company Profiles
9.3.1 GlaxoSmithKline plc
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Geographic foothold
9.3.1.4 Product benchmarking
9.3.1.5 Strategic initiatives
9.3.2 Philips Respironics
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Geographic foothold
9.3.2.4 Product benchmarking
9.3.2.5 Strategic initiatives
9.3.3 Boehringer Ingelheim GmbH
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Geographic foothold
9.3.3.4 Product benchmarking
9.3.3.5 Strategic initiatives
9.3.4 Novartis AG
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Geographic foothold
9.3.4.4 Product benchmarking
9.3.4.5 Strategic initiatives
9.3.5 3M Healthcare
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 GF Health Products, Inc.
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.7 Merck & Co., Inc.
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Geographic foothold
9.3.7.4 Product benchmarking
9.3.8 AstraZeneca
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Geographic foothold
9.3.8.4 Product benchmarking
9.3.8.5 Strategic initiatives
List of Tables
TABLE 1 Country share estimation
TABLE 2 North America pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
TABLE 3 North America pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 4 North America pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 5 North America pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 6 North America pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 7 U.S. pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 8 U.S. pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 9 U.S. pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 10 U.S. pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 11 Canada pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 12 Canada pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 13 Canada pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 14 Canada pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 15 Europe pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
TABLE 16 Europe pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 17 Europe pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 18 Europe pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 19 Europe pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 20 UK pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 21 UK pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 22 UK pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 23 UK pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 24 Germany pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 25 Germany pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 26 Germany pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 27 Germany pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 28 Asia Pacific pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
TABLE 29 Asia Pacific pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 30 Asia Pacific pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 31 Asia Pacific pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 32 Asia Pacific pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 33 Japan pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 34 Japan pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 35 Japan pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 36 Japan pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 37 China pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 38 China pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 39 China pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 40 China pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 41 India pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 42 India pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 43 India pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 44 India pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 45 Latin America pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
TABLE 46 Latin America pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 47 Latin America pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 48 Latin America pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 49 Latin America pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 50 Brazil pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 51 Brazil pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 52 Brazil pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 53 Brazil pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 54 Mexico pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 55 Mexico pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 56 Mexico pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 57 Mexico pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 58 MEA pulmonary drug delivery systems market, by country, 2017 - 2026 (USD Million)
TABLE 59 MEA pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 60 MEA pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 61 MEA pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 62 MEA pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
TABLE 63 South Africa pulmonary drug delivery systems market, by product, 2017 - 2026 (USD Million)
TABLE 64 South Africa pulmonary drug delivery systems market, by application, 2017 - 2026 (USD Million)
TABLE 65 South Africa pulmonary drug delivery systems market, by distribution channel, 2017 - 2026 (USD Million)
TABLE 66 South Africa pulmonary drug delivery systems market, by end use, 2017 - 2026 (USD Million)
List of Figures
FIG. 1 Market summary
FIG. 2 Market trends &outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Pulmonary drug delivery systems market: Company share analysis, 2018
FIG. 10 Pulmonary drug delivery systems market, product outlook: Key takeaways
FIG. 11 Pulmonary drug delivery systems market: Product movement analysis
FIG. 12 Metered dose inhalers (MDIs) market, 2017 - 2026 (USD Million)
FIG. 13 Dry powder inhalers (DPIs) market, 2017 - 2026 (USD Million)
FIG. 14 Nebulizers market, 2017 - 2026 (USD Million)
FIG. 15 Mesh nebulizers market, 2017 - 2026 (USD Million)
FIG. 16 Vibrating mesh nebulizers market, 2017 - 2026 (USD Million)
FIG. 17 Static mesh nebulizers market, 2017 - 2026 (USD Million)
FIG. 18 Pneumatic nebulizers market, 2017 - 2026 (USD Million)
FIG. 19 Vented pneumatic nebulizers market, 2017 - 2026 (USD Million)
FIG. 20 Breath actuated pneumatic nebulizers market, 2017 - 2026 (USD Million)
FIG. 21 Ultrasonic nebulizers market, 2017 - 2026 (USD Million)
FIG. 22 Accessories market, 2017 - 2026 (USD Million)
FIG. 23 Pulmonary drug delivery systems market, application outlook: Key takeaways
FIG. 24 Pulmonary drug delivery systems market: Application movement analysis
FIG. 25 Asthma market, 2017 - 2026 (USD Million)
FIG. 26 Cystic fibrosis market, 2017 - 2026 (USD Million)
FIG. 27 Chronic obstructive pulmonary disease market, 2017 - 2026 (USD Million)
FIG. 28 Allergic rhinitis market, 2017 - 2026 (USD Million)
FIG. 29 Others market, 2017 - 2026 (USD Million)
FIG. 30 Pulmonary drug delivery systems market, distribution channel outlook: Key takeaways
FIG. 31 Pulmonary drug delivery systems market: distribution channel movement analysis
FIG. 32 Retail pharmacies market, 2017 - 2026 (USD Million)
FIG. 33 Hospital pharmacies market, 2017 - 2026 (USD Million)
FIG. 34 E-commerce market, 2017 - 2026 (USD Million)
FIG. 35 Pulmonary drug delivery systems market, end use outlook: Key takeaways
FIG. 36 Pulmonary drug delivery systems market: End use movement analysis
FIG. 37 Hospitals & clinics market, 2017 - 2026 (USD Million)
FIG. 38 Homecare market, 2017 - 2026 (USD Million)
FIG. 39 Regional market place: Key takeaways
FIG. 40 Regional outlook, 2018 & 2026
FIG. 41 Strategy framework
FIG. 42 Market participation and categorization
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers